IHE · iShares
iShares U.S. Pharmaceuticals ETF
See how 60 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.
Core valuation
Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.
Largest reported holdings
| Holding | Weight | Trailing P/E | Trailing P/S |
|---|---|---|---|
| JNJJOHNSON & JOHNSON | 22.13% | 29.63× | 6.37× |
| LLYELI LILLY | 21.57% | 40.52× | 13.59× |
| MRKMERCK & CO INC | 5.00% | 111.82× | 5.33× |
| BMYBRISTOL MYERS SQUIBB | 4.71% | 13.53× | 2.55× |
| RPRXROYALTY PHARMA PLC CLASS A | 4.39% | 39.52× | 12.66× |
| PFEPFIZER | 4.28% | 36.99× | 2.52× |
| VTRSVIATRIS | 4.02% | -48.83× | 1.36× |
| ZTSZOETIS INC CLASS A | 3.73% | 10.83× | 3.00× |
| JAZZJAZZ PHARMACEUTICALS PLC | 3.37% | 16.08× | 3.29× |
| ELANELANCO ANIMAL HEALTH | 2.53% | -54.66× | 2.17× |
Top 10 of 60 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.
Most similar funds
Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.
- PPH · VanEck Pharmaceutical ETF44.53% holdings overlap · Nasdaq
- XPH · State Street SPDR S&P Pharmaceuticals ETF38.77% holdings overlap · NYSE Arca
- FTXH · First Trust Nasdaq Pharmaceuticals ETF38.40% holdings overlap · Nasdaq
- IYH · iShares U.S. Healthcare ETF37.02% holdings overlap · US market
- XLV · State Street Health Care Select Sector SPDR ETF36.87% holdings overlap · US market
Sources and limitations
Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.
Open official holdings sourceResearch holdings date: 21 August 2026. Informational research, not investment advice.